Tocilizumab in the treatment of COVID-19—a meta-analysis
Volume: 114, Issue: 8, Pages: 577 - 586
Published: May 19, 2021
Abstract
Interleukin-6 inhibitors showed promising results in observational trials of patients with coronavirus disease 2019 (COVID-19).To evaluate whether interleukin-6 inhibitor tocilizumab (TCZ) reduces mortality among hospitalized COVID-19 patients.A systematic review and meta-analysis.Systematic review and meta-analysis of randomized controlled trials (RCTs) comparing TCZ vs. placebo/control, for treatment of adults with COVID-19. Primary outcome...
Paper Details
Title
Tocilizumab in the treatment of COVID-19—a meta-analysis
Published Date
May 19, 2021
Volume
114
Issue
8
Pages
577 - 586
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History